JP6382311B2 - 損傷組織の再生 - Google Patents

損傷組織の再生 Download PDF

Info

Publication number
JP6382311B2
JP6382311B2 JP2016533753A JP2016533753A JP6382311B2 JP 6382311 B2 JP6382311 B2 JP 6382311B2 JP 2016533753 A JP2016533753 A JP 2016533753A JP 2016533753 A JP2016533753 A JP 2016533753A JP 6382311 B2 JP6382311 B2 JP 6382311B2
Authority
JP
Japan
Prior art keywords
wound
tropoelastin
composition
epithelialization
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016533753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527979A5 (enExample
JP2016527979A (ja
Inventor
アンソニー・スティーブン・ワイス
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elastagen Pty Ltd
Original Assignee
Elastagen Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903092A external-priority patent/AU2013903092A0/en
Application filed by Elastagen Pty Ltd filed Critical Elastagen Pty Ltd
Publication of JP2016527979A publication Critical patent/JP2016527979A/ja
Publication of JP2016527979A5 publication Critical patent/JP2016527979A5/ja
Application granted granted Critical
Publication of JP6382311B2 publication Critical patent/JP6382311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
JP2016533753A 2013-08-13 2014-08-13 損傷組織の再生 Active JP6382311B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
AU2013903092 2013-08-13
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018145202A Division JP6639587B2 (ja) 2013-08-13 2018-08-01 損傷組織の再生

Publications (3)

Publication Number Publication Date
JP2016527979A JP2016527979A (ja) 2016-09-15
JP2016527979A5 JP2016527979A5 (enExample) 2017-08-17
JP6382311B2 true JP6382311B2 (ja) 2018-08-29

Family

ID=52467858

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016533753A Active JP6382311B2 (ja) 2013-08-13 2014-08-13 損傷組織の再生
JP2018145202A Active JP6639587B2 (ja) 2013-08-13 2018-08-01 損傷組織の再生
JP2019232193A Active JP6891257B2 (ja) 2013-08-13 2019-12-24 損傷組織の再生

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2018145202A Active JP6639587B2 (ja) 2013-08-13 2018-08-01 損傷組織の再生
JP2019232193A Active JP6891257B2 (ja) 2013-08-13 2019-12-24 損傷組織の再生

Country Status (12)

Country Link
US (4) US20160194379A1 (enExample)
EP (2) EP4316537A3 (enExample)
JP (3) JP6382311B2 (enExample)
KR (3) KR102488446B1 (enExample)
CN (2) CN110464837A (enExample)
AU (3) AU2014306362B2 (enExample)
BR (1) BR112016003082A8 (enExample)
CA (1) CA2920312C (enExample)
ES (1) ES2965893T3 (enExample)
MX (2) MX377200B (enExample)
RU (1) RU2677637C2 (enExample)
WO (1) WO2015021508A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9688741B2 (en) 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2702602T3 (es) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Fabricación de construcciones tridimensionales elásticas escalables
EP4316537A3 (en) 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
AU2016314775A1 (en) * 2015-09-01 2018-03-22 Allergan Pharmaceuticals International Limited Formation of bone
CN110121369A (zh) * 2016-11-04 2019-08-13 艾尔建制药国际有限公司 生物合成装置
CA3136074A1 (en) * 2019-05-03 2020-11-12 Robert Daniels Scar prevention and/or treatment
US20230310552A1 (en) * 2020-09-08 2023-10-05 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
ATE102631T1 (de) 1988-11-11 1994-03-15 Medical Res Council Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
CA2057014C (en) 1990-03-30 2001-07-24 Toshihiko Kaminuma Process for purification of polypeptide
WO1994007921A1 (en) 1992-09-25 1994-04-14 Commonwealth Scientific And Industrial Research Organisation Target binding polypeptide
NZ258820A (en) * 1992-12-22 1997-07-27 Univ Sydney Recombinant tropoelastins and their preparation
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) * 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
EP0922058A2 (en) 1996-08-07 1999-06-16 Protein Specialities Ltd. Self-aligning peptides derived from elastin and other fibrous proteins
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
CA2279902C (en) 1997-02-07 2009-01-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
WO1999011196A1 (en) 1997-09-04 1999-03-11 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US7109292B2 (en) 1999-03-08 2006-09-19 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
EP1196510A4 (en) * 1999-05-28 2007-01-17 Providence Health Sys Oregon PROCESSES FOR PRODUCING LAMINATED ELASTIN, ELASTIN-BASED MATERIALS, AND TROPOELASTINE-BASED PRODUCTS FOR REPAIRING AND / OR REPLACING FABRICS
DK1229940T3 (da) 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
WO2002096978A1 (en) 2001-05-30 2002-12-05 Keiichi Miyamoto Crosslinked elastin and process for producing the same
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
CA2846382C (en) 2004-02-20 2017-09-19 The Hospital For Sick Children Manganese based compounds for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
CA2602947A1 (en) 2005-03-24 2006-09-28 Straumann Holding Ag Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
US20090169593A1 (en) 2005-10-19 2009-07-02 Biomedical Research Services, Inc. Method of using and producing tropoelastin and tropoelastin biomaterials
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
AU2007285483B2 (en) 2006-05-11 2011-12-22 Regenics As Administration of cells and cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
US7700126B2 (en) 2006-09-29 2010-04-20 Martin Kean Chong Ng Tropoelastin-based protoelastin biomaterials
BRPI0718615B8 (pt) * 2006-11-13 2021-06-22 Allergan Australia Pty Ltd processo para produzir um material elástico a partir de tropoelastina e material elástico
WO2009015372A1 (en) * 2007-07-25 2009-01-29 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
WO2009018546A1 (en) 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
US9421305B2 (en) 2008-02-01 2016-08-23 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
EP3881825B1 (en) * 2009-03-10 2024-12-25 Allergan Pharmaceuticals International Limited Injectable biomaterials
PL2550027T5 (pl) 2010-03-22 2019-07-31 Allergan, Inc. Polisacharydowe i białkowo-polisacharydowe usieciowane hydrożele do powiększania tkanek miękkich
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
EP4043043A1 (en) 2010-11-23 2022-08-17 Allergan Pharmaceuticals International Limited Preparation and/or formulation of proteins cross-linked with polysaccharides
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
US9114128B2 (en) * 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
EP3505180B1 (en) 2011-09-30 2022-08-03 Allergan Pharmaceuticals International Limited In vivo synthesis of elastic fiber
US9688741B2 (en) * 2012-10-23 2017-06-27 Elastagen Pty Ltd Elastic hydrogel
ES2702602T3 (es) 2012-12-10 2019-03-04 Allergan Pharmaceuticals Int Ltd Fabricación de construcciones tridimensionales elásticas escalables
EP4316537A3 (en) * 2013-08-13 2024-04-10 Allergan Pharmaceuticals International Limited Regeneration of damaged tissue
KR20200138836A (ko) 2013-09-24 2020-12-10 앨러간 파마슈티컬스 인터내셔널 리미티드 단백질 추출 방법

Also Published As

Publication number Publication date
WO2015021508A1 (en) 2015-02-19
JP6639587B2 (ja) 2020-02-05
AU2014306362B2 (en) 2019-04-18
RU2677637C2 (ru) 2019-01-18
BR112016003082A8 (pt) 2020-01-28
RU2016104618A3 (enExample) 2018-06-18
US20220098281A1 (en) 2022-03-31
AU2019204972A1 (en) 2019-08-01
CN105530951B (zh) 2019-10-22
MX2016001436A (es) 2016-07-05
US20250171522A1 (en) 2025-05-29
AU2021245202A1 (en) 2021-11-04
US20190062405A1 (en) 2019-02-28
JP6891257B2 (ja) 2021-06-18
AU2021245202B2 (en) 2025-01-23
KR20210154881A (ko) 2021-12-21
CN110464837A (zh) 2019-11-19
JP2020049282A (ja) 2020-04-02
CA2920312A1 (en) 2015-02-19
US20160194379A1 (en) 2016-07-07
MX2020011880A (es) 2021-01-20
KR102488446B1 (ko) 2023-01-13
MX377200B (es) 2025-03-07
KR20160041949A (ko) 2016-04-18
AU2019204972B2 (en) 2021-07-08
EP4316537A3 (en) 2024-04-10
KR20230004965A (ko) 2023-01-06
EP3033099B1 (en) 2023-11-01
RU2016104618A (ru) 2017-09-14
EP3033099A1 (en) 2016-06-22
CA2920312C (en) 2022-07-19
BR112016003082A2 (pt) 2017-08-01
EP4316537A2 (en) 2024-02-07
JP2016527979A (ja) 2016-09-15
JP2018164789A (ja) 2018-10-25
AU2014306362A1 (en) 2016-02-18
CN105530951A (zh) 2016-04-27
ES2965893T3 (es) 2024-04-17
EP3033099A4 (en) 2017-04-12
US11084867B2 (en) 2021-08-10

Similar Documents

Publication Publication Date Title
JP6891257B2 (ja) 損傷組織の再生
Lorenz et al. Wounds: biology, pathology, and management
US20100239556A1 (en) Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system
US20240293596A1 (en) Compositions and methods for treating wounds
Ksander et al. Inhibition of connective tissue formation in dermal wounds covered with synthetic, moisture vapor-permeable dressings and its reversal by transforming growth factor-β
HK40016252A (zh) 受损组织的再生
US20240016893A1 (en) Compositions and methods for treating wounds
Lorenz et al. Wounds: Biology
Nath A Clinical Study on the Efficacy of Autologous Platelet Rich Plasma in the Management of Chronic Non Healing Ulcers
Charles et al. 19 Active Treatments for Acute and Chronic Wounds
Charles et al. 19 Active Treatments for
Lorenz et al. Wounds: Biology, Pathology, and
HK1160164A (en) Promoting ecm production by fibroblast cells and/or promoting migration of fibroblast cells in a biological system

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170705

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170705

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20180312

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180320

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180619

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180703

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180801

R150 Certificate of patent or registration of utility model

Ref document number: 6382311

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250